Latest Celebrex news
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACR: Chondroitin Sulfate Cuts Cartilage Volume Loss in Knee OA
posted November 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with knee osteoarthritis, chondroitin sulfate is associated with additional benefits in terms of cartilage volume loss compared with celecoxib, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in San Francisco.
Robotic Arm-Assisted TKR Offers Similar Outcome to Conventional TKR
Review Reveals Limited Effects of Exercise on Hip Osteoarthritis
Oral Microbiome Dysbiosis Linked to Symptomatic Hand Osteoarthritis
Long-Term Outcomes Favor Patellar Resurfacing During Total Knee Replacement
Adenotonsillectomy Tied to Increase in Respiratory Tract Infections in Children
Preoperative Chemo + Immunotherapy Combo Shrinks Head, Neck Cancer Tumors
Safety Intervention Reduces Incidence of Postoperative Endophthalmitis
First Metatarsophalangeal Joint Arthrodesis Eases Painful Hallux Rigidus